Company Terminal

Profluent

Profluent is an AI-first protein design company that uses generative foundation models to write novel proteins and biological molecules from scratch. Its platform targets therapeutic proteins, antibodies, enzymes, and gene editors — including OpenCRISPR-1, an openly released AI-designed CRISPR gene editor.

Momentum
Not scored
as of 2026-08-03
Funding
—
Founded
—
Stack
—
Research Tier A
0%
needs citations
Momentum inputsNot scored · need ≥2 signals · as of 2026-08-03

No momentum signals yet for this company. See docs/MOMENTUM.md.

No radar series.

Linked model value

    No headcount (est.) series yet.
    No capital raised (est.) series yet.
    No monthly web attention (est.) series yet.
    No geographic reach (countries, est.) series yet.

    Research completeness

    • Tier A: 0% (0/0)
    • Tier B: 0% · Tier C: 0%
    • Publish gate: Blocked
    Open in Research Desk →

    Citations / claims

    No claims yet. Run seed_provenance_tier_a.sql or add sources in Research Desk.

    What they do

    Who is this for? Teams evaluating AI vendors in this category.

    Why different? Profluent is an AI-first protein design company that uses generative foundation models to write novel proteins and biological molecules from scratch. Its platform targets therapeutic proteins, antibodies, enzymes, and gene editors — including OpenCRISPR-1, an openly released AI-designed CRISPR gene editor.

    Models & technologies

    No owned model versions linked yet.

    Competitors

    Provenance

    Profile loaded from supabase. Claims and metric observations carry confidence labels; prefer primary URLs in Research Desk over estimate backfills.